gold-investing Orsu Metals Identifies the Southwestern Extension of Zone 23 at Its Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Announces Stage 1 of the 2019 Exploration Program that Aims to Expand the Mineralization Envelope at Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Files Maiden Inferred Mineral Resource Technical Report for Its Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Announces a Maiden Inferred Mineral Resource at Its Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Demonstrates up to 89% Recovery from Initial Metallurgical Tests on Primary Sulphide Material at the Klyuchi West zone, Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Further Extends Zone 23 from 740 Meters to 900 Meters and has Started Estimation Work for a Maiden Resource with Wardell Armstrong International at Its Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals Recent Drilling Connects Kozie and Klyuchi West Occurrences into a Single 750-m-Long and 250-m-Wide Stockwork at Its Sergeevskoe Gold Project, Russia
gold-investing Orsu Metals hits 4.12 g/t Au over 10.25 Meters near Surface in Drill Hole SDH18-63 and Grows Gold Mineralization over a 740 m Strike Length at Zone 23, Sergeevskoe Gold Project, Russia
EMP METALS ADVANCES CONSTRUCTION OF PROJECT AURORA DEMONSTRATION PLANT BY COMPLETING INTERIOR FINISHING
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
